• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.37% Nasdaq Down 0.28%

    Seattle Genetics, Inc. (SGEN)

    -NasdaqGS
    59.27 Up 0.23(0.39%) Jan 19, 4:00PM EST
    |After Hours : 59.27 0.00 (0.00%) Jan 19, 4:29PM EST
    Prev Close:59.04
    Open:N/A
    Bid:N/A
    Ask:N/A
    1y Target Est:58.93
    Beta:2.28247
    Earnings Date:Feb 7 - Feb 13 (Est.)
    Day's Range:N/A - N/A
    52wk Range:26.02 - 75.36
    Volume:0
    Avg Vol (3m):1,399,180
    Market Cap:8.39B
    P/E (ttm):N/A
    EPS (ttm):-0.78
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for SGEN

    Comparison

    Symbol% ChgMkt Cap
    SGENUp 0.39%8.39B
    IMGNUp 0.81%216.51M
    1 0.00%N/A
    PFEDown 1.03%192.37B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):20.57
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-0.94
    Quarterly EPS Est (Dec-16) :-0.33
    Mean Recommendation*:2.5
    PEG Ratio (5 yr expected):-3.62

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Seattle Genetics, Inc., a biotechnology company, develops and commercializes targeted therapies for the treatment of cancer worldwide. It markets ADCETRIS (brentuximab vedotin), an antibody-drug conjugate for the treatment of relapsed Hodgkin lymp... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback